Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PCYC-1137
PCYC-1137
AbbVie's Imbruvica misses pancreatic cancer endpoints
BioCentury
Fri, 01/18/19 - 09:16 pm
AbbVie
Imbruvica
clinical trials
PCYC-1137
metastatic pancreatic cancer